Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 7, 2015; 21(25): 7754-7763
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7754
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7754
Figure 4 Ezetimibe increases autophagosome formation and autophagic flux in hepatocytes.
Electron microscopy of hepatocytes demonstrated ezetimibe-induced autophagy (A). Representative blot (B) and quantitative analysis (C) expressed as LC3-II (14 kDa)/LC3-I (16 kDa) followed by sample/control (mean ± SE). aP < 0.05, bP < 0.01, vs control in the absence of PA and BAF; cP < 0.05, PA vs PA + Ez in the absence of BAF; dP < 0.01, vs control in the absence of PA but in the presence of BAF. fP < 0.01, PA vs PA + Ez in the presence of BAF. BAF: Bafilomycin A1; Con: Control; Ez: Ezetimibe; PA: Palmitic acid.
- Citation: Chang E, Kim L, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY. Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. World J Gastroenterol 2015; 21(25): 7754-7763
- URL: https://www.wjgnet.com/1007-9327/full/v21/i25/7754.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i25.7754